Prognosis
EU Health Ministers Debate Astra Shot After Halting Vaccine
- Drug regulator to hold press conference 2 p.m. Brussels time
- Multiple countries have suspended use of Astra shots
This article is for subscribers only.
European health ministers are discussing the future of AstraZeneca Plc’s Covid-19 vaccine as they await fresh guidance from the region’s drug regulator in response to concerns about health risks.
The European Medicines Agency will hold a press conference on Tuesday afternoon, bringing forward a planned review by two days amid a fresh vaccine crisis. A growing number of countries have suspended use of Astra’s shot to examine side effects, potentially throwing the region’s already slow inoculation campaign further off track.